Skip to main content

Table 1 Baseline characteristics of patients at enrollment

From: Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality

Number of patients 142
Patient sex Men: 90 (63.4%)
Women: 52 (36.6%)
Patient age (median, years) 58
Range (years) 20–77
Median MELD score 12
Range 6–40
Etiology of liver disease (including multiple nominations)
 - Alcoholic 89 (62.7%)
 - Cryptogenic 19 (13.4%)
 - Viral 9 (6.3%)
 - NASH 9 (6.3%)
 - Autoimmune hepatitis 6 (4.2%)
 - PBC/PSC 2 (1.4%)
 - Hepatocellular carcinoma 11 (7.7%)
Cholesterol ester  
 Median (Range) [mg/dl] 154.3 (7.7–310.6)
 Median (Range) [mmol/l] 3.98 (0.20–8.01)
Total cholesterol  
 Median (Range) [mg/dl] 210.8 (41.3–493.7)
 Median (Range) [mmol/l] 5.44 (1.07–12.74)
Cholesterol esterification fraction (median (Range)) 73% (19–80%)
  1. PBC Primary Biliary Cholangitis, PSC Primary Sclerosing Cholangitis